Effects of Tanshinone Ⅱ A on MMP-2 and TIMP-1 in Continuous Ambulatory Peritoneal Dialysis Patients

Cheng SUN,Miao ZHANG,Chun-ming JIANG
DOI: https://doi.org/10.3969/j.issn.1008-8199.2011.09.005
2011-01-01
Abstract:Objective The imbalance of matrix metalloproteinases-2(MMP-2) and its tissue inhibitor-1(TIMP-1) is responsible for the deposition of extracellular matrix components involved in tissue fibrosis,including peritoneal fibrosis.This study was to investigate the effects of Tanshinone ⅡA on cell proliferation activity and the secretion of MMP-2 and TIMP-1 in human peritoneal mesothelial cells(HPMC) cultured in vitro with peritoneal dialysate(PDS) as well as the impact of Tanshinone ⅡA on MMP-2 and TIMP-1 of peritoneal cavity in continuous ambulatory peritoneal dialysis(CAPD) patients.Methods HPMCs were cultured in vitro and divided into five groups: control,PDS,and 1mg/L,5mg/L and 10mg/L Tanshinone ⅡA.After 48 h incubation,the levels of MMP-2 and TIMP-1 in the supernatant and the expressions of MMP-2 and TIMP-1mRNA in the HPMCs were determined by ELISA and RT-PCR,respectively.Thirty-eight stable CAPD patients were randomized to an experimental and a control group of equal number,the former treated by injection of PDS with Tanshinone ⅡA(10 mg/2L) for 3 weeks and PDS alone for another 3,while the latter without Tanshinone ⅡA throughout the 6 weeks.The concentrations of MMP-2 and TIMP-1 in the effluent were assayed at 0,3 and 6 weeks and compared among different groups.Results Significant increases were observed in the level of MMP-2 in the supernatant,the ratio of MMP-2 to TIMP-1,and the expression of MMP-2mRNA in HPMCs in the PDS group as compared with the control(P0.05).After Tanshinone ⅡA intervention,the concentration of MMP-2 in the effluent was significantly lower than that before treatment(P0.05) and higher than that at 6 weeks(P0.05),while no significant difference was found in TIMP-1 in the effluent.Conclusion Tanshinone ⅡA can significantly decrease the PDS-induced high expression of MMP-2mRNA and improve the proliferation activity of HPMCs,adjust the balance of MMP-2 and TIMP-1,and decrease the level of MMP-2 in peritoneal cavity in CAPD patients.
What problem does this paper attempt to address?